Prophylactic Pretransplant Ganciclovir to Reduce Cytomegalovirus Infection After Hematopoietic Stem Cell Transplantation
Daniel Reed(Oklahoma State University), Karen K. Ballen(University of Virginia Health System), Sandra Monson(University of Virginia), Gerald R. Donowitz(University of Virginia), Leonid Volodin(University of Virginia), Indumathy Varadarajan(University of Virginia), Melissa West, Kyle Grose(University of Kansas), Paige G. Williams(University of Virginia), Abeer Alfaraj(Hematology Oncology Associates), Gina R. Petroni(University of Virginia Health System), Kathlene DeGregory(University of Virginia), Tamila L. Kindwall‐Keller(MetroHealth Medical Center), Caroline Jones(The University of Western Australia)
Cited by 6
Related Papers
Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever
|New England Journal of Medicine|2002|986
Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia
|New England Journal of Medicine|2004|922
Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial
|Clinical Infectious Diseases|2006|752
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
|New England Journal of Medicine|2018|598